1. Introduction {#sec1}
===============

Hospital-acquired infections (HAIs), also known as nosocomial infections, are caused by viral, bacterial, and fungal pathogens; the most common types are bloodstream infection (BSI), ventilator-associated pneumonia (VAP), urinary tract infection (UTI), and surgical site infection (SSI), as explained by K. Woeltje et al. \[[@B1]\]. Such infections can be acquired in hospital or in other clinical settings. The infection may be spread by various means to the susceptible patient in the clinical settings. These means may include infected staff, infected patients, contaminated equipment, bed linen, or air droplets. The source of the infection may also come from the outside environment, or from other sources that cannot be determined, or after a surgery that compromises the protective skin barrier. The Centers for Disease Control and Prevention (CDC) estimated roughly 1.7 million hospital-associated infections in the United States from all types of microorganisms. These included bacteria and fungi combined, causing about ninety-nine thousand deaths each year as described by Haidee and Russell \[[@B2]\].

In Europe, where hospital surveys have been conducted, "gram-negative infections are estimated to account for two-thirds of the 25,000 deaths each year" \[[@B3]\]. Nosocomial infections can cause severe pneumonia and infections of the urinary tract and bloodstream. Many types of nosocomial infections are hard to treat with antibiotics. In addition, antibiotic resistance can complicate treatment.

Central Line Associated Bloodstream Infections (CLABSI) are serious infections typically causing a prolongation of hospital stay and increased cost and risk of mortality. However, "CLABSI can be prevented through proper insertion techniques and management of the central line". These techniques are addressed by the CDC\'s Healthcare Infection Control Practices Advisory Committee (CDC/HIPAC) \[[@B5]\].

This paper describes a web-based, multitiered surveillance system for predicting and reducing CLABSI. The word "multitiered" means that the system can work using actual patients\' real data collected from the web-resources and from hospitals databases. It can also work using patients\' data records that can be generated for training by the built-in system simulator; i.e., the system works in two levels of data (actual data and the simulated data). CLABSI is "a primary laboratory confirmed bloodstream infection in a patient with a central line at the time of (or within 48-hours prior to) the onset of symptoms and the infection is not related to an infection from another site" \[[@B3]\]. The blood cultures must be taken from the central line and simultaneously from a peripheral vein, with a shorter time to positivity in the central line sample. Several researchers have tackled the problem of detecting and preventing CLABSI hospital-acquired infections. However, in developed countries it is difficult to get patient data available in electronic formats suitable for use in computing facilities. Even most of the available patients\' data in the hospitals are written in paper format and are mostly confidential. To overcome these problems, we have built a simulator to generate CLABSI patients\' data records to be able to build and test our proposed system; in addition, it transforms a patient\'s paper records into an electronic format. This proved very helpful as a system for training healthcare staff members and nurses. The system uses multimedia so that diagnosis reports can be produced in the form of text tables as well as in the form of colored graphics and charts.

The rest of the paper covers the following: [Section 2](#sec2){ref-type="sec"} discusses types of surveillance systems and comparison. [Section 3](#sec3){ref-type="sec"} describes materials and methods. [Section 4](#sec4){ref-type="sec"} explains system results and discussions, and [Section 5](#sec5){ref-type="sec"} is the conclusion.

2. Surveillance Systems Comparison {#sec2}
==================================

Healthcare-associated infections (HAIs) are a major global public health concern. In developing countries, the lack of surveillance systems leads to an underestimation of the global burden of HAI as explained by Maha Talaat et al. \[[@B4]\]. CLABSIs still occur in intensive care units in developed countries (high income countries) in the US and Europe \[[@B5]\] and in the developing countries (middle/low income countries) in Asia and Africa. Intensive care units (ICUs) in countries with limited resources "have rates of device-associated healthcare-associated infection including CLABSI, VAP, and catheter-associated urinary tract infection (CAUTI) that are 3 to 5 times higher than rates reported from North American, Western European, and Australian ICUs", as explained by Victor D. Rosenthal et al. \[[@B6]\].

Although computer algorithms to detect bloodstream infections can be used to reduce CLABSI, as described by Trick et al. \[[@B7]\], they stated that "automated bloodstream infection surveillance with electronic data is an accurate alternative to surveillance with manually collected data". Also, a comparison of automated strategies for surveillance of nosocomial bacteremia was investigated by Cristina Bellini et al. \[[@B8]\]. They concluded that automated strategies are convenient alternatives to manual surveillance of nosocomial BSI. An automated CLABSI surveillance approach has also several advantages, including reducing the time spent by infection control specialists on routine surveillance and reallocating it to prevention efforts and potentially extending surveillance outside of the intensive care unit (ICU) \[[@B9]\].

Automated algorithmic approaches for translating manual infection control surveillance methods were explained by Bala Hota et al. \[[@B11]\]. The goal was to automat infection detection that would achieve the CDC aim and to improve the financial support for hospitals to deploy electronic health records.

A semiautomated electronic surveillance system for ventilator-associated pneumonia (VAP) and CLABSI in a Dutch intensive care unit was described by Anna Maria Kaiser \[[@B12]\]. They concluded that surveillance of VAP and CLABSI with a trigger-based electronic surveillance system (ESS) is feasible and effective because of its time-saving benefits. An automated surveillance system was described by Keith F. Woeltje \[[@B10]\]; it uses existing databases with patient-level variables and microbiology data. It can perform acceptably good surveillance in areas where resources do not allow for traditional manual surveillance.

Due to the unavailability of patient data and confidentiality issues, specifically in developing countries simulated patient records can be used. Simulation-based training associated with reduced CLABSI rates was used by Gilman B. Allen \[[@B13]\]. In their medical and surgical intensive care units, they obtained the benefits of simulation training, electronic medical records, and standardized kits to reduce their CLABSI rates. The several benefits of CLABSI simulation training were explained by Karla M. Abela \[[@B17]\], among which there is the following: learning environment is safe. Teaching methodology is flexible. Patient safety is not compromised. Feedbacked data can be structured immediately. Student focused learning may be individualized. Simulation-based training can significantly improve nurses\' education quality and hence leads to reduced CLABSI rates as explained by Khouli H et al. \[[@B18]\] and by Barsuk JH. et al. \[[@B19]\]. Also, simulation training can produce significant medical care cost savings, as explained by Elaine R. Cohen \[[@B20]\].

3. Materials and Methods {#sec3}
========================

This section describes the architecture of the proposed system, including materials used and methods.

3.1. System Hardware Components {#sec3.1}
-------------------------------

[Figure 1](#fig1){ref-type="fig"} shows the system hardware web components developed, based on oracle architecture. To ensure system data protection activity and to ensure security and safety, the following steps has been implemented:Users are connected to the Hospital Servers through firewalls.Users are connected to fill data through a secure Java Web start application maintained by Oracle Web-Logic Server.Data and application stores in Server Cluster are protected using Antivirus Software Security.Also, the data is secured by Default Oracle Database Security.The Clinical Infections Department at King Abdulaziz University Hospital was connected to the system during the experimental stage; it covers 750 beds.Several local hospitals are connected to the system during the experimental stage.

3.2. System Software Components {#sec3.2}
-------------------------------

The proposed system software is constructed of six components (modules), as shown in [Figure 2](#fig2){ref-type="fig"}. These include the Patients\' Data Module (PDM), the CLABSI algorithm Module (CAM), the Symptoms and Criteria Module (SCM), the Risk Indicators Module (RIM), the Contamination Module (CM), and the Simulator module (SM). The functions of these components are described in the following sections, respectively.

### 3.2.1. Patients\' Data Module (PDM) {#sec3.2.1}

This software component is responsible for collecting patients\' data from several resources from hospitals locally or remotely from the portal web site. This can be done using many IT resources including iPhones, iPad, laptops, the Internet, scanners, and hospital databases. [Table 1](#tab1){ref-type="table"} shows a part of the primary bloodstream infections entry form and instructions for completion \[[@B14]\]. To detect if a patient has a CLABSI infection or not, additional patient data including symptoms criteria is inputted to the surveillance system proposed, as explained in the next sections.

### 3.2.2. CLABSI Algorithm Module (CAM) {#sec3.2.2}

This system software component is responsible for applying the standard CLABSI algorithm as shown in [Figure 2](#fig2){ref-type="fig"}. It is used for diagnosis patients\' data collected. A positive blood culture with signs and symptoms of infection are evidence of a bloodstream infection. A patient may develop a CLABSI case, whens/he suffers from fevers, chills, or the skin around the catheter may become sore and red.When a bloodstream infection occurs and there is no other place where that infection could be coming from.The infection is associated with the central line.It is still possible that the infection could be coming from another place but that source is hidden \[[@B15]\].

The CLABSI algorithm deals with these symptoms to know and detect the type of infection, as explained in [Section 3.2.3](#sec3.2.3){ref-type="sec"}.

### 3.2.3. Symptoms and Criteria Module (SCM) {#sec3.2.3}

This system software component is responsible for finding out CLABSI symptoms and evaluating their criteria, for diagnosis of patients\' data. We built the list of CLABSI symptoms and criteria based on hospital-acquired infection definition described in \[[@B15], [@B14]\]. In our experimental stage, we have applied twenty-four CLABSI predictors that are shown in [Table 2](#tab2){ref-type="table"}. They can be used effectively for predicting patients\' infections.

### 3.2.4. Risk Indicators Module (RIM) {#sec3.2.4}

This system software component is utilized to estimate patient illness due to predicted infection, as shown in [Table 3](#tab3){ref-type="table"}.

The risk indicator software module computes total symptoms weights and indicates CLABSI prediction results, in the form of colors, as shown in [Table 3](#tab3){ref-type="table"}. [Table 4](#tab4){ref-type="table"} shows CLABSI predictors and symptoms in detail and the VALUE-LABLE risk weights (high, mild, low, and no risk) used for infection prediction. Four levels of infection indicators (A, B, C, and D) are proposed. Red color indicates CLABSI high risk (A), when sum of high symptoms criteria weights was more than or equal five. Orange color indicates CLABSI mild risk (B) when sum of mild symptoms criteria weights was more than or equal five. Yellow color indicates CLABSI low risk (C) when sum of low symptoms criteria weights was more than or equal five. Green color indicates no risk (D) when sum of normal symptoms criteria weights was more than or equal five. At least the sum of a total of five symptoms criteria should be achieved to justify an infected prediction for CLABSI patient cases.

Using of color indicators are an appropriate classification of the patients\' risk of developing CLABSI, because it is based on the electronic hospital-acquired infection surveillance Phoenix system used at KAUH, which uses colors. And we established it based on other classification, such as ASA (American Society of Anesthesiologists) physical status classification system \[[@B21]\]. Also, the color indicators are suitable for providing a quick vision test, for indicator that can be figured out by staff members and nurses, specifically suitable in case of training. In addition, the system can also produce detailed results of patients\' diagnosis data in the form of tables and charts, as explained in next sections.

### 3.2.5. Contamination Module (CM) {#sec3.2.5}

This system software component is responsible for*producing feedback information* after a diagnosis of a CLABSI patient case. It tells the nurses and medical staff whether the patient is now infected or not. If a patient is infected, patient treatment by staff and nurses should be carried out quickly to cure the patient safely. Then, the system continues to remeasure the patient case, until s/he is recovered from the infection.

### 3.2.6. Simulator Module (SM) {#sec3.2.6}

This system software component was built to simulate patient data records automatically, when required for training. It is used for testing the system\'s CLABSI prediction and patient data validation. In addition, it is used for nurses\' education and medical staff training. To proof that the simulator generates patients\' data records and gives almost identical results as the actual patients\' data records, the following steps are implemented:The simulator generates patient prediction records randomly. These records are generated by Oracle database procedure.The prediction values are selected from a predefined set of values. These procedure uses the default Oracle random procedure.The interdependencies of predictors have been implemented (like birth weight predictor links with newborn predictor, parenteral nutrition links with gender or multiple insertion with status of procedure).By default, the procedure generates 10 patients\' records. To proof that simulation results are equivalent and almost identical into real results, we apply the same algorithms and formulas used in the case of actual data.The simulator algorithm checks if the predictor\'s values are valid as the actual values, then results will be accepted.

[Figure 3](#fig3){ref-type="fig"}, for example, shows a sample of a simulator generated patient records. When comparing this simulated patient data records with the actual real data records, as shown in [Figure 5](#fig5){ref-type="fig"}, it indicates that the results obtained are identical.

4. Results and Discussions {#sec4}
==========================

4.1. Patient Information Input Screen {#sec4.1}
-------------------------------------

The results explained here are based on real patients\' data from King Abdulaziz University Hospital (KAUH), containing 750 beds, dept. of clinical infection control. [Figure 4](#fig4){ref-type="fig"} shows the patient information input screen. [Figure 5](#fig5){ref-type="fig"} shows the event details input screen. The built-in simulator is an additional facility for generating artificial patient data records that can be used when needed by staff and nurses to input simulated patient data records for training and education. The proposed WMSS-CLABSI system produces several types of charts, graphs, tables, and reports of patients\' information, including infection detection and diagnosis. [Figure 6](#fig6){ref-type="fig"} shows patient event details of the data entry form. [Figure 7](#fig7){ref-type="fig"} shows a sample of patient record details and patient predictors information.

4.2. Reports Generated and Risk Prediction {#sec4.2}
------------------------------------------

[Figure 8](#fig8){ref-type="fig"} shows a sample of the generated prediction summary report. It indicates patient\'s number of records, event dates, and symptoms with diagnosis indicators. Based on these patients\' information, the percentage of infections risk can be computed as indicated in [Table 5](#tab5){ref-type="table"}. It shows the theoretically percentage of types of CLABSI risk for each group (defined in [Table 4](#tab4){ref-type="table"}) including high, mild, low, and normal risks. Each cell value in [Table 5](#tab5){ref-type="table"} is computed by dividing predicted numbers of CLABSI risk types by total symptoms (24) multiplied in 100.

4.3. Device Utilization and Standard Infection Ratios {#sec4.3}
-----------------------------------------------------

Figures [9(a)](#fig9){ref-type="fig"} and [9(b)](#fig9){ref-type="fig"} show a bar graph chart indicating the relationship between Central Line Days (CLDs), Patient Days (PDs), and Device Utilization Ratio (DUR) as a function of time (in months). For example, it shows that, during July, the CLDs=85 and PDs=153, then DUR = 85 / 153 = 0.38.

Figures [10(a)](#fig10){ref-type="fig"} and [10(b)](#fig10){ref-type="fig"} show some results using bar chart graphs for computing the standard infection ratio (SIR) as a function of time. SIR is computed by dividing CLABSI observed cases over CLABSI predicted cases. It is one of the important measures for judging the quality of a hospital\'s CLABSI detection and prevention. The standard value of SIR is one. When SIR has a value below one it indicates better hospital safety and vice versa. The higher ratio of SIR reflects a need for stronger CLABSI prevention efforts, while the lower SIR ratio reflects a robust CLABSI prevention strategies \[[@B22]\].

[Figure 10(b)](#fig10){ref-type="fig"} shows that there is a regularly smooth reduction in SIR ratio, as function of time (in months). This is a good indication factor. The average SIR ratio within the 1^st^ six months (from Jan. up to Jun.) is 0.86, based on CLABSI traditional manual method used. And during the next six months (from Jul. up to Dec.), the average SIR ratio within these six months is 0.73, where the automated proposed method was used. These results give a reduction in the SIR ratio = 86-73=13%. Hence, the system improvement value = 87%. This proves that the proposed automated system gives improvement in CLABSI prediction performance better than the traditional manual method. Hence, based on these results, applying the proposed method achieves better regular reduction in SIR, as function of time in months, and better than that achieved by the manual method.

5. Conclusions {#sec5}
==============

This paper presented a new web-based, multitiered surveillance system for predicting central line associated bloodstream infections (CLABSI). The system collects patients\' data from several resources including laptops, Internet, scanners, and hospitals databases. This process helps hospitals to gather patients\' data efficiently and accurately. Patients\' records are automatically processed for CLABSI diagnoses and prediction based on knowledge discovery CLABSI algorithms. This helps to reduce the process of infection prediction time and hence reduce CLABSIs rates. The outputs of predicted infected cases are produced using visualized multimedia forms including text reports, colored risk indicators, and graphic charts. This helps medical decision makers to review and approve policies for surveillance plans. The system has also a built-in simulator to simulate specific patient data records, when needed, for nurses\' training and education. This helps in reducing and preventing many CLABSIs cases and hence keeps a hospital safe while reducing treatment costs. We are currently expanding the WMSS-CLABSI system to include ventilator-associated pneumonia (VAP), urinary tract infection (UTI), and surgical site infection (SSI), at King Abdulaziz University Hospital, in Jeddah, Saudi Arabia.
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###### 

Primary bloodstream infection (BSI) form and instructions for completion (CDC 57.108) \[[@B3]\].

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Data Field           Instructions for Data Collection
  -------------------- ------------------------------------------------------------------------------------------------------------------------------------
  Facility ID          It will be auto entered by the computer.

                       

  Event \#             It will be auto entered by the computer.

                       

  Patient ID           Required. Enter the alphanumeric patient ID number.\
                       It consists of any combination of numbers and/or letters.

                       

  Social Security \#   Optional. Enter the 9-digit numeric patient Social Security Number.

                       

  Secondary ID         Optional. Enter the alphanumeric ID number assigned\
                       by the facility.

                       

  Medicare \#          Conditionally required. Enter the patient\'s Medicare number for all events reported as part of a CMS Quality Reporting Program.

                       

  Patient name         Optional. Enter the last, first, and middle name of the patient.

                       

  Gender               Required. Check Female, Male, or Other to indicate the\
                       gender of the patient.

                       

  Date of Birth        Required. Use this format: MM/DD/YYYY.

                       

  Ethnicity            Optional.

                       

  Race                 Optional.

                       

  Event type           Required. BSI.

                       

  Date of event        Required to meet the BSI criterion occurred for the first time, during the Infection Window Period, using this format: MM/DD/YYYY.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of CLABSI predictors.

  -------------------------------------------------------------------------------
  [List of predictions]{.ul}:
   (1) Multiple insertion.
   (2) Site of insertion (femoral, subclavian, jugular).
   (3) Rewire (Yes or No).
   (4) Status of Procedure (Elective or Emergency).
   (5) Co-morbidities (drop down selections):
    (a) DM (Diabetes Mellitus),
    (b) HTN (Hypertension),
    (c) BA (Bronchial Asthma),
    (d) Malignancy,
    (e) Heart Disease etc.
   (6) Compliant to Central Line Insertion & Maintenance bundle (Yes or No).
   (7) Length of stay (*›*14 days).
   (8) Parenteral nutrition (Yes or No).
   (9) Antimicrobial usage (Yes or No).
   (10) Renal failure (Yes or No).
   (11) Surgical procedure (Yes or No).
   (12) Age.
   (13) Sex (Male or Female).
   (14) Duration of device use.
   (15) Transfer from other hospital (Yes or No).
   (16) Transfer from other unit within the hospital (Yes or No).
   (17) Co-existing infection (Yes or No).
   (18) Temperature: (on admission & 48 hrs. after insertion).
   (19) APACHE Score: 0-14(MILD); 15-29(MODERATE); ≥30 (SEVERE).
   (20) Ventilated (Yes or No).
  In addition, for neonates & children.
   (21) Birth weight (≤750gm; 750-1000gm; 1001-1500gm; 1501-2500gm; *›*2500gm).
   (22) Nasal CPAP (Yes or No).
   (23) Blood Transfusion (Yes or No).
   (24) Trauma (Yes or No).
  -------------------------------------------------------------------------------

###### 

CLABSI indicators due to total symptom weightings.

  Patient case Category   Symptoms weight           Type of Risk   Color Indicator
  ----------------------- ------------------------- -------------- -----------------
  A                       If sum of High symptoms   high risk      Red
  Criteria weights \>=5                                            
  B                       If sum of Mild symptoms   mild risk      Orange
  Criteria weights \>=5                                            
  C                       If sum of low symptoms    low risk       Yellow
  Criteria weights \>=5                                            
  D                       If sum of symptoms        no risk        Green
  Criteria weights \< 5                                            

###### 

CLABSI symptoms used criteria for CLABSI infection prediction.

  **No**   **PRD_NAME**                                               **VALUE_LABLE**           **VALUE_LEVEL**   **No**   **PRD_NAME**                                   **VALUE_LABLE**     **VALUE_LEVEL**
  -------- ---------------------------------------------------------- ------------------------- ----------------- -------- ---------------------------------------------- ------------------- -----------------
  1        Site of insertion                                          No Risk                   No Risk           37       Age                                            Premature           High Risk
                                                                                                                                                                                              
  2        Site of insertion                                          subclavian                Low Risk          38       Surgical procedure                             No Risk             No Risk
                                                                                                                                                                                              
  3        Site of insertion                                          jugular                   Mild Risk         39       Surgical procedure                             Yes                 High Risk
                                                                                                                                                                                              
  4        Site of insertion                                          femoral                   High Risk         40       Sex                                            No Risk             No Risk
                                                                                                                                                                                              
  5        Rewire                                                     No Risk                   No Risk           41       Sex                                            Female              Low Risk
                                                                                                                                                                                              
  6        Rewire                                                     Yes                       High Risk         42       Sex                                            Male                High Risk
                                                                                                                                                                                              
  7        Status of Procedure                                        No Risk                   No Risk           43       Duration of device use                         No Risk             No Risk
                                                                                                                                                                                              
  8        Status of Procedure                                        Elective                  Low Risk          44       Duration of device use                         1 to 5 days         Low Risk
                                                                                                                                                                                              
  9        Status of Procedure                                        Emergency                 High Risk         45       Duration of device use                         6 to 10 days        Mild Risk
                                                                                                                                                                                              
  10       Co-morbidities                                             No Risk                   No Risk           46       Duration of device use                         More than 10 days   High Risk
                                                                                                                                                                                              
  11       Co-morbidities                                             Sickle Cell Anemia        High Risk         47       Transfer from other hospital                   No Risk             No Risk
                                                                                                                                                                                              
  12       Co-morbidities                                             BA(Bronchial Asthma)      High Risk         48       Transfer from other hospital                   Yes                 High Risk
                                                                                                                                                                                              
  13       Co-morbidities                                             Meningitis                High Risk         49       Transfer from other unit within the hospital   No Risk             No Risk
                                                                                                                                                                                              
  14       Co-morbidities                                             Pulmonary Tuberculosis    High Risk         50       Transfer from other unit within the hospital   Yes                 High Risk
                                                                                                                                                                                              
  15       Co-morbidities                                             Myocardial Infacrtion     High Risk         51       Co-existing infection                          No Risk             No Risk
                                                                                                                                                                                              
  16       Co-morbidities                                             Chronic Liver Disease     High Risk         52       Co-existing infection                          Yes                 High Risk
                                                                                                                                                                                              
  17       Co-morbidities                                             Malignancy                High Risk         53       Temperature                                    No Risk             No Risk
                                                                                                                                                                                              
  18       Co-morbidities                                             HTN(Hypertension)         High Risk         54       Temperature                                    Yes                 High Risk
                                                                                                                                                                                              
  19       Co-morbidities                                             DM(Diabetes Mellitus)     High Risk         55       APACHE Score                                   No Risk             No Risk
                                                                                                                                                                                              
  20       Co-morbidities                                             Cerebral Infarction       High Risk         56       APACHE Score                                   0 to 14             Low Risk
                                                                                                                                                                                              
  21       Co-morbidities                                             Heart Disease             High Risk         57       APACHE Score                                   15-29               Mild Risk
                                                                                                                                                                                              
  22       Compliant to Central Line Insertion & Maintenance bundle   Yes                       No Risk           58       APACHE Score                                   \>= 30              High Risk
                                                                                                                                                                                              
  23       Compliant to Central Line Insertion & Maintenance bundle   No                        High Risk         59       Ventilated                                     No Risk             No Risk
                                                                                                                                                                                              
  24       Length of Stay                                             No Risk                   No Risk           60       Ventilated                                     Yes                 High Risk
                                                                                                                                                                                              
  25       Length of Stay                                             Less than equal 14 days   Mild Risk         61       Birth weight                                   No Risk             No Risk
                                                                                                                                                                                              
  26       Length of Stay                                             More than 14 days         High Risk         62       Birth weight                                   \>2500              Low Risk
                                                                                                                                                                                              
  27       Parenteral nutrition                                       No Risk                   No Risk           63       Birth weight                                   1000-1500           Mild Risk
                                                                                                                                                                                              
  28       Parenteral nutrition                                       Yes                       High Risk         64       Birth weight                                   1501-2500           Mild Risk
                                                                                                                                                                                              
  29       Antimicrobial usage                                        No Risk                   No Risk           65       Birth weight                                   \<= 750 gm          High Risk
                                                                                                                                                                                              
  30       Antimicrobial usage                                        Yes                       High Risk         66       Birth weight                                   750-1000 gm         High Risk
                                                                                                                                                                                              
  31       Renal failure                                              No Risk                   No Risk           67       Nasal CPAP                                     No Risk             No Risk
                                                                                                                                                                                              
  32       Renal failure                                              Yes                       High Risk         68       Nasal CPAP                                     Yes                 High Risk
                                                                                                                                                                                              
  33       Age                                                        No Risk                   No Risk           69       Blood Transfusion                              No Risk             No Risk
                                                                                                                                                                                              
  34       Age                                                        Adult                     Low Risk          70       Blood Transfusion                              Yes                 High Risk
                                                                                                                                                                                              
  35       Age                                                        New Born                  Mild Risk         71       Trauma                                         No Risk             No Risk
                                                                                                                                                                                              
  36       Age                                                        Elderly                   High Risk         72       Trauma                                         Yes                 High Risk

###### 

Percentage of the several categories of CLABSI risk.

  Percentage of Risk of CLABSI for Each Group                                                                                   
  --------------------------------------------- -------------------- ------------------- ------------------- ------------------ --------
  900088                                        ***12/24=50%***      2/24=8.44%          1/24=4.17%          9/24=37.5%         High
                                                                                                                                
  900096                                        4/24=16.67%          1/24=4.17%          ***5/24=20.83%***   14/24=58.33%       Low
                                                                                                                                
  900100                                        4/24=16.67%          ***5/24=20.83%***   2/24=8.44%          13/24=54.17%       Mild
                                                                                                                                
  900124                                        4/24=16.67%          4/24=16.67%         3/24=12.5%          **13/24=54.17%**   Normal
                                                                                                                                
  900203                                        ***9/24=37.5%***     1/24=4.17%          3/24=12.5%          11/24=45.83%       High
                                                                                                                                
  900593                                        ***16/24=66.67%***   1/24=4.17%          2/24=8.44%          5/24=20.83%        High
                                                                                                                                
  900653                                        ***12/24=50%***      2/24=8.44%          1/24=4.17%          9/24=37.5%         High
                                                                                                                                
  900753                                        ***11/24=45.83%***   3/24=12.5%          3/24=12.5%          7/24=29.17%        High
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